VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ULBI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ULBIUltralife Corporation
$6.03$100M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksULBIBalance Sheet

Ultralife Corporation (ULBI) Balance Sheet

30Y historyFree accessUpdated daily

The company has aggressively deleveraged, reducing its debt-to-equity ratio from 0.38 in 2025Q4 to 0.03 in 2026Q1, though this is tempered by a substantial $45.3 million goodwill balance representing over 20% of total assets.

ULBI Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97Jun'96
Total Current Assets110.1M105.8M97.16M90.2M78.99M66.52M64.5M70.37M67.22M61.92M49.51M51.95M56.83M58.81M63.82M64.23M75.65M75.96M75.17M68.29M55.88M39.36M40.18M32.56M13.75M13.99M21.31M29.4M38.5M25.2M36.8M
Cash & Short-Term Investments8.89M9.35M6.85M10.28M5.71M8.41M10.65M7.41M25.93M18.33M10.71M14.53M17.87M16.49M10.08M5.49M5.11M6.09M1.88M2.25M720K3.21M11.53M830K2.02M1.67M10.99M17.9M2.4M2.8M1.2M
Cash Only8.89M9.35M6.85M10.28M5.71M8.41M10.65M7.41M25.93M18.33M10.71M14.53M17.87M16.49M10.08M5.49M5.11M6.09M1.88M2.25M720K3.21M10.53M830K2.02M706K1.37M2.2M2.4M2.8M1.2M
Short-Term Investments00000000000000000000001M02K968K9.62M15.7M000
Accounts Receivable34.43M33.95M29.37M31.76M27.78M20.23M21.05M30.11M16.02M14.66M13.18M11.61M11.48M14.42M21.64M21.85M34.27M32.45M30.59M26.54M24.2M10.96M8.59M20.15M6.05M4.43M3.38M3.1M3.1M5.1M2.7M
Days Sales Outstanding63.9464.8265.1873.0776.9175.1571.34102.967.0462.5558.3455.4363.0166.7877.6857.2270.0568.8243.8370.494.4156.7731.9292.5867.966.8650.353.6368.99117.0865.26
Inventory57.29M54.01M51.36M42.22M41.19M33.19M28.19M29.76M22.84M26.33M23.46M23.81M26.09M26.05M30.37M34.97M33.12M35.5M40.47M35.1M27.36M19.45M13.94M10.21M4.63M5.46M5.44M6.8M4.1M3.5M8.4M
Days Inventory Outstanding134.27134.42153.49129146.77164.54131143.62135.34162.04149.28163.66201.96169.16152122.7391.5895.8174.69117.72131.22121.8765.3259.7654.2671.9484.56147.74114.2492.57245.28
Other Current Assets9.5M8.5M004.3M4.69M1.59M0089K77K409K445K700K1.71M327K672K288K441K461K855K2.99M4.28M50K1.05M1.3M1.51M1.6M28.9M13.8M22.3M
Total Non-Current Assets110.53M111.11M123.29M88.07M89.44M93.01M73.2M74.18M52.88M35.27M35.23M29.62M30.79M31.41M33.9M36.58M39.18M55.21M54.41M53.76M41.88M41.4M40.95M19.8M16.32M32.25M34.92M35.9M32.1M24.7M23.8M
Property, Plant & Equipment40.12M40.4M44.64M24.71M23.9M25.79M22.85M22.52M10.74M7.57M8M9.04M9.81M10.2M12.41M12.59M14.48M16.65M18.46M19.36M19.4M19.93M20.2M18.21M16.13M32.02M33.84M32.5M31.4M24.1M10.7M
Fixed Asset Turnover4.45x4.73x3.68x6.42x5.52x3.81x4.71x4.74x8.12x11.30x10.31x8.46x6.78x7.73x8.19x11.07x12.33x10.34x13.79x7.11x4.82x3.54x4.86x4.36x2.02x0.75x0.72x0.65x0.52x0.66x1.41x
Goodwill45.33M45.38M45.01M37.57M37.43M38.07M27.02M26.75M20.11M20.46M19.96M16.28M16.41M16.42M16.34M18.36M18.28M25.44M22.94M21.18M13.34M0000000000
Intangible Assets10.65M10.93M24.56M15.11M15.92M17.39M9.21M9.72M6.5M7.08M7.19M3.95M4.34M4.65M5.04M5.53M6.15M13.06M12.93M13.11M9.07M000183K233K332K0000
Long-Term Investments00000000-82K-157K-166K-401K-341K-360K-218K-266K-478K-348K-441K-309K-75K0000000000
Other Non-Current Assets3.67M3.91M9.09M122K121K298K2.29M1.96M82K125K72K309K235K269K98K105K270K60K81K97K66K18.96M17.67M1.58M00749K3.4M700K600K13.1M
Total Assets220.63M216.91M220.45M178.28M168.43M159.54M137.7M144.56M120.1M97.19M84.74M81.57M87.62M90.22M97.72M100.81M114.83M131.17M129.59M122.05M97.76M80.76M81.13M52.35M30.06M46.24M56.23M65.3M70.6M49.9M60.6M
Asset Turnover0.85x0.88x0.75x0.89x0.78x0.62x0.78x0.74x0.73x0.88x0.97x0.94x0.76x0.87x1.04x1.38x1.56x1.31x1.97x1.13x0.96x0.87x1.21x1.52x1.08x0.52x0.44x0.32x0.23x0.32x0.25x
Asset Growth %56%-1.61%23.66%5.85%5.57%15.86%-4.74%20.36%23.58%14.68%3.89%-6.91%-2.88%-7.68%-3.07%-12.21%-12.45%1.22%6.18%24.85%21.05%-0.46%54.98%74.14%-34.99%-17.76%-13.89%-7.51%41.48%-17.66%-3.19%
Total Current Liabilities43.05M37.33M29.29M23.73M28.91M18.92M18.71M17.19M14.95M14.24M11.33M10.86M11.19M12.02M19.9M23.16M36.34M48.13M32.24M41.83M37.81M18.38M9.54M17.85M8.8M7.09M7.04M5.8M5.9M6.4M4.2M
Accounts Payable24.06M17.42M14.16M11.34M16.07M9.82M10.84M9.39M9.92M8.79M7.29M6.49M7M7.05M11.36M13.77M16.34M19.18M20.25M18.33M15.93M5.22M3.54M6.38M3.09M4.37M3.3M3M3.9M3.8M2.7M
Days Payables Outstanding44.2243.3642.3134.6457.2748.750.3645.3158.7754.0946.4144.6354.1645.856.8448.3245.1751.7537.3861.4776.3832.716.6137.3836.257.5651.365.18108.66100.5178.84
Short-Term Debt3.44M4.13M2.75M2M2.9M2.87M1.36M1.37M000000008.72M19.08M1.43M13.42M12.25M7.71M2.39M8.29M3.15M955K1.15M200K100K00
Deferred Revenue (Current)298K000119K000-439K000001.85M1.79M2.89M3.34M4.53M1.9M0940K885K821K694K000000
Other Current Liabilities15.56M15.79M298K287K6.93M4.39M00-121K168K172K227K69K103K4.63M6.01M-2.75M4.27M3.9M8.18M8.34M4.51M2.72M2.35M1.86M1.76M2.59M2.6M1.9M2.6M1.5M
Current Ratio2.56x2.83x3.32x3.80x2.73x3.52x3.45x4.09x4.50x4.35x4.37x4.78x5.08x4.89x3.21x2.77x2.08x1.58x2.33x1.63x1.48x2.14x4.21x1.82x1.56x1.97x3.02x5.07x6.53x3.94x8.76x
Quick Ratio1.23x1.39x1.56x2.02x1.31x1.76x1.94x2.36x2.97x2.50x2.30x2.59x2.75x2.72x1.68x1.26x1.17x0.84x1.08x0.79x0.75x1.08x2.75x1.25x1.04x1.20x2.25x3.90x5.83x3.39x6.76x
Cash Conversion Cycle153.99155.87176.36167.43166.4190.99151.98201.21143.61170.5161.21174.46210.81190.15172.84131.64116.45112.8881.14126.66149.26145.9380.62114.9785.9681.2483.56136.1974.57109.14231.7
Total Non-Current Liabilities47.83M49.45M56.97M29.12M23.11M22.87M2.07M17.62M623K3.9M5.56M4.65M4.52M4.55M4.37M4.43M4.7M4.92M9.2M17.21M20.36M267K7.97M68K103K2.2M3.12M400K100K100K3.4M
Long-Term Debt045.53M51.5M23.62M19.31M18.86M015.78M00000000251K267K4.67M16.22M20.04M25K7.21M68K103K2.2M3.12M500K100K00
Capital Lease Obligations5.07M03M2.64M1.31M1.74M1.52M1.25M376K00000000200K00025K000000000
Deferred Tax Liabilities3.33M1M01.71M1.92M2.25M515K559K623K3.9M5.56M4.65M4.52M4.24M4.16M4.17M3.91M4.1M3.89M0021.22M20.42M00000000
Other Non-Current Liabilities46.87M2.92M2.47M1.14M17K17K1.56M-528K-344K018K28K56K283K210K261K538K351K634K985K316K217K756K0000-100K0100K0
Total Liabilities90.89M86.78M86.26M52.85M52.03M41.8M20.78M34.81M15.57M18.14M16.88M15.51M15.71M16.57M24.27M27.59M41.04M53.05M41.43M59.04M58.17M18.65M17.51M17.92M8.9M9.29M10.16M6.2M6M6.5M4.2M
Total Debt3.44M49.65M58.39M29.16M23.51M23.47M3.56M19.02M815K00000008.97M19.35M6.09M29.65M32.29M7.74M9.61M8.36M3.25M3.16M4.27M700K200K00
Net Debt-5.45M40.31M51.53M18.88M17.8M15.05M-7.09M11.61M-25.12M-18.33M-10.71M-14.53M-17.87M-16.49M-10.08M-5.49M3.86M13.26M4.22M27.4M31.57M4.53M-924K7.53M1.24M2.45M2.9M-1.5M-2.2M-2.8M-1.2M
Debt / Equity0.03x0.38x0.44x0.23x0.20x0.20x0.03x0.17x0.01x-------0.12x0.25x0.07x0.47x0.82x0.12x0.15x0.24x0.15x0.09x0.09x0.01x0.00x--
Debt / EBITDA0.37x3.37x4.13x2.18x5.12x6.57x0.41x1.88x0.09x---------0.26x4.96x16.91x27.74x1.14x0.92x-------
Net Debt / EBITDA-0.59x2.74x3.65x1.41x3.88x4.21x-0.82x1.15x-2.81x-2.06x-1.65x-4.08x---26.31x-0.81x--0.18x4.58x16.54x16.22x-0.11x0.83x-------
Interest Coverage1.02x2.33x5.28x5.52x0.53x0.38x17.11x13.56x104.05x35.39x15.44x14.03x-7.27x-2.57x-0.30x4.74x10.25x-4.92x19.10x--10.06x-2.28x0.56x--1353.03x-10.98x---2.86x--
Total Equity129.75M130.13M134.19M125.43M116.4M117.74M116.92M109.75M104.53M79.05M67.86M66.06M71.91M73.64M73.45M73.23M73.8M78.11M88.15M63.01M39.59M62.11M63.63M34.43M21.16M36.95M46.07M59.1M64.6M43.4M56.4M
Equity Growth %-1.98%-3.02%6.98%7.75%-1.14%0.7%6.54%4.99%32.24%16.49%2.72%-8.14%-2.35%0.26%0.31%-0.77%-5.53%-11.39%39.91%59.15%-36.26%-2.39%84.8%62.68%-42.73%-19.78%-22.05%-8.51%48.85%-23.05%-2.76%
Book Value per Share7.797.828.007.737.227.347.266.786.394.984.414.024.124.224.224.224.304.604.994.052.664.274.222.471.713.324.225.647.755.487.23
Total Shareholders' Equity129.63M130M134M125.33M116.28M117.62M116.8M109.73M104.62M79.2M68.03M66.2M72.03M73.74M73.52M73.26M73.77M78.06M88.13M63.01M39.59M62.11M63.63M34.43M21.16M36.95M46.07M59.1M64.6M43.4M56.4M
Common Stock2.11M2.11M2.11M2.08M2.06M2.05M2.04M2.03M2M1.97M1.93M1.92M1.9M1.89M1.89M1.87M1.86M1.83M1.81M1.71M1.58M1.55M1.5M1.43M1.34M1.26M1.15M1.1M000
Retained Earnings-40.79M-40.34M-34.44M-40.75M-47.95M-47.83M-47.6M-52.83M-57.96M-82.89M-90.54M-94.05M-96.92M-94.8M-93.88M-92.28M-90.2M-84.02M-74.78M-88.44M-94.03M-66.54M-62.19M-84.53M-86.91M-68.79M-53.3M-39.1M-30.1M-22.9M-12.9M
Treasury Stock0-21.49M-21.49M-21.49M-21.48M-21.47M-21.32M-21.23M-19.27M-18.47M-18.44M-17.81M-8.42M-7.66M-7.66M-7.66M-7.65M-7.56M-4.23M-2.4M-2.38M-2.38M-2.38M-2.38M0-303K-303K-300K000
Accumulated OCI-3.06M-3.14M-4.01M-3.66M-3.75M-1.65M-1.78M-2.53M-2.79M-1.61M-3.08M-863K-467K-614K-620K-985K-1.26M-1.26M-1.93M69K-321K-1.05M-605K-723K-856K-835K-864K600K-4.7M-3.1M-1.9M
Minority Interest119K139K192K95K126K127K123K24K-85K-154K-170K-143K-114K-99K-65K-34K24K54K21K000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetHealthy
Cash FlowDeteriorating
Top Statement Risk

Working capital and margin volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Asset Expansion Outpacing Equity Growth

According to the provided quarterly balance sheets, Ultralife's total assets have increased from $178.3 million in 2023Q4 to $220.6 million in 2026Q1, yet this expansion has not translated into equity growth, as retained earnings remain deeply negative at -$40.8 million, signaling a disconnect between asset accumulation and profitability.

The growth in the asset base appears to be driven by acquisition-related goodwill and increased property, plant, and equipment, rather than organic earnings retention. This trajectory suggests that management is prioritizing scale through inorganic means, which warrants caution given the lack of corresponding improvement in bottom-line performance.

Conservative Leverage Amidst Operational Losses

Based on reported financial statements, Ultralife maintains a conservative capital structure with a debt-to-equity ratio of 0.03 as of 2026Q1, a significant reduction from the 0.38 observed in 2025Q4, indicating that the company has utilized its cash position to aggressively deleverage despite ongoing net losses.

The rapid reduction in debt suggests a strategic preference for balance sheet safety over financial leverage, likely to mitigate risks associated with the cyclical nature of defense contracting. While this low leverage provides a buffer against insolvency, it also highlights the company's limited reliance on external financing to fund its current operational deficits.

Goodwill Concentration and Asset Quality

As reported in the quarterly filings, goodwill accounts for $45.3 million of the $220.6 million in total assets as of 2026Q1, representing a significant portion of the company's book value and suggesting that future asset quality is heavily dependent on the performance of past acquisitions.

The concentration of intangible assets relative to tangible property, plant, and equipment of $40.1 million implies that the company's valuation is sensitive to impairment risks if acquired business units fail to meet growth expectations. Investors should monitor whether these intangible assets continue to represent a growing share of the balance sheet, as this could indicate a reliance on acquisition-driven growth rather than internal innovation.

Liquidity Buffer Remains Structurally Sound

According to the latest balance sheet data, Ultralife maintains a current ratio of 2.56 as of 2026Q1, which, while lower than the 3.32 peak observed in 2024Q4, continues to provide a sufficient liquidity cushion to cover short-term obligations despite the company's recent negative net margin performance.

The company's ability to maintain a current ratio well above 2.0 suggests that it is not currently facing immediate liquidity constraints, even as cash balances have fluctuated. However, the reliance on current assets to support operations in the absence of consistent profitability warrants close monitoring of the cash conversion cycle and working capital efficiency.

Accumulated Deficit Masks Operational Challenges

Based on the company's reported figures, the persistent negative retained earnings balance of -$40.8 million as of 2026Q1 serves as a critical indicator that historical operational losses have eroded shareholder equity, potentially masking the true economic cost of the company's recent growth and acquisition strategy.

The fact that retained earnings have remained consistently negative over the last ten quarters suggests that the company has struggled to generate sustainable value for shareholders despite revenue growth. This structural deficit implies that the balance sheet's apparent health is supported more by capital preservation than by the successful compounding of earnings, which may limit future capital allocation flexibility.

ULBI — Frequently Asked Questions

Quick answers to the most common questions about buying ULBI stock.

What are the total assets of Ultralife Corporation (ULBI)?

As of 2025, Ultralife Corporation (ULBI) had total assets of $216.9M including $105.8M in current assets.

How much debt does Ultralife Corporation (ULBI) have?

Ultralife Corporation (ULBI) carries total debt of $49.7M, offset by $9.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Ultralife Corporation?

Ultralife Corporation (ULBI) has total shareholders' equity (book value) of $130.0M ($7.82 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Ultralife Corporation's current ratio and liquidity?

Ultralife Corporation (ULBI) reported a current ratio of 2.83x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.